Table 2.
Angiographic results
| Variables | BMI (%) | P | |||
|---|---|---|---|---|---|
| (≤20 kg/m2) (n = 60) | (20.0–24.9 kg/m2) (n = 489) | (25.0–29.9 kg/m2) (n = 447) | (≥30.0 kg/m2) (n = 81) | ||
| Left main disease | 0 (0.0) | 48 (9.8) | 52 (11.6) | 6 (7.4) | 0.033 |
| Vessel involved | |||||
| 1 vessel disease | 7 (11.7) | 93 (19.0) | 77 (17.2) | 12 (14.8) | 0.472 |
| 2 vessel disease | 17 (28.3) | 151 (30.9) | 120 (26.8) | 24 (29.6) | |
| 3 vessel disease | 36 (60.0) | 245 (50.1) | 250 (55.9) | 45 (55.6) | |
| Type C lesion | 36 (60.0) | 267 (54.6) | 247 (55.3) | 36 (44.4) | 0.247 |
| CTO lesion | 14 (23.3) | 82 (16.8) | 69 (15.4) | 9 (11.1) | 0.250 |
| Ostium lesion | 6 (10.0) | 69 (14.1) | 61 (13.6) | 10 (12.3) | 0.830 |
| Birfurcation lesion | 22 (36.7) | 172 (35.2) | 199 (31.1) | 30 (37.0) | 0.480 |
| Use of DES | 52 (86.7) | 467 (95.5) | 430 (96.2) | 79 (97.5) | <0.01 |
| Number of stents | |||||
| 1 | 30 (50.0) | 230 (47.0) | 190 (42.) | 36 (44.4) | 0.685 |
| 2 | 18 (30.0) | 161 (32.9) | 147 (32.9) | 26 (32.1) | |
| ≥3 | 12 (20.0) | 98 (20.0) | 110 (24.6) | 19 (23.5) | |
| Use of IVUS | 3 (5.0) | 21 (4.3) | 22 (4.9) | 3 (3.7) | 0.945 |
| Use of IABP | 3 (5.0) | 15 (3.1) | 13 (2.9) | 1 (1.2) | 0.631 |
| Final TIMI 3 flow | 55 (91.7) | 484 (99.0) | 437 (97.8) | 81 (100) | <0.01 |
| Radial route | 47 (78.3) | 378 (77.3) | 345 (77.2) | 62 (76.5) | 0.996 |
| Coronary dissection | 0 (0.0) | 8 (1.6) | 4 (0.9) | 0 (0.0) | 0.393 |
| Coronary thrombosis | 0 (0.0) | 4 (0.8) | 2 (0.4) | 0 (0.0) | 0.685 |
| Access site complications | 4 (6.7) | 21 (4.3) | 14 (3.1) | 3 (3.7) | 0.544 |
CTO: Chronic total occlusion; DES: Drug-eluting stent; IABP: Intra-aortic balloon pump; IVUS: Intravascular ultrasound; TIMI: Thrombolysis in myocardial infarction.